Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
ยฃ1.80 to be precise.
Micky, The shareprice can go to whatever it wants. We have had forecasts of 10, 15, 25 and even 30p. Some of those are above even my optimistic estimates, but certainly 10p is achievable.
However my point is that WHATEVER price we get to, be it 6, 8, 10p+ Prevail will still get another chance to invest at 6p, thats the sweetener they got to come on board early. That is my belief but still just a guess.
IF they do then some people may see it as negative they got such a big discount but IMO anyone who says that now? They have an opportunity to buy today at 3.3p. Another key point:
Prevail and Hemogenyx valued the company for the 6p placing by looking at the value of the company, the SP was not relevant. Prevail were given a 1% stake in Hemogenyx in exchange for getting the company ready for Trials. Its likely they will get another, larger stake in Hemogenyx when they are ready to start trials to pay for them. EVEN if it is at 6p the chances of Prevail selling is very unlikely, they invest in companies, they are not traders.
PK, not sure it matters if we are correct and its Prevail, IMO there will be a bit of a lag between CH being lifted and the funding being announced, IMO they have already fixed their price on 6p, we just got a taster before, so even if SP IS 10p+ its still going to be 6p. But IMO if/when that happens we have no right to complain given they have helped get us to this point.
CBR works against NHL :P but yea CAR-T is AML, no question that Hemo are undervalued. HOWEVER as nice as the numbers are.... Vlad is not going to get that far, 99.9999% he sells it before it goes commercial, Hemo are an R&D company they will prove it works and sell it, IMO 500m'ish.
You can watch the interview with Vlad, its 10 days for Hemogenyx. However he has commented on new technology and approaches which are starting to appear that could bring that down to 1 day in the future.
Spot on Socialist, mix of new "Trader" investors yesterday + shorts closing although some still open needing to close. And I agree once that RNS DOES land Hemogenyx are suddenly classified as Clinical and IMO will have an mCap > 50mil so suddenly the pool of investors willing to invest here will expand significantly. Just need to flip that switch and then things get interesting.
3.35p with a UT of 3.4 so we are going to open RED tomorrow!!!!
However last time there was a UT it was significantly UNDER the spread so we opened blue allowing MMs to move us down to hide the actual drop. So it APPEARS that the general behaviour is, the UT denotes direction for following day trading. But it can easily be manipulated by PIs and should not be taken as anything more than an interesting trend.
For all his faults he is still human, think he had a sizeable holding in GWMO and PROBABLY is holding here also, 30% up on GW and almost 30% up here. Hopefully he will make his money and retire for good from the trolling business and enjoy the better side of life :-)
If you want a laugh.... Spreadex still showing 17% short and IG showing 7% short :P clampits! :P
Yep, I dont know what the market will do when CH is lifted, alot depends on Vlad, if he keeps any dilution/placing limited to Prevail and II which would most likely hold for Clinical Trials then Hemo could easily head up to that 300m target mCap so 10-20p is absolutely possible. With 500m shares in private hands(simply wall St) I personally know ATLEAST 10% of those are in the hands of people I know who are unlikely to sell many on IND and are waiting for CBR, so with an increase volume and buying we could see some stupid increases here.
There is no debt
There are no warrant holders outside of Hemogenyx (its unlikely Vlad will convert and sell)
So yea, there is every chance this does a 10x in the coming weeks, but for now? I would love 5p before IND approval and 8-10p post approval, that would be a good result for me and IMO very achievable.
Purely speculation:
As a Clinical Oncology with CAR- T in trials it would still be one of, if not the cheapest(considering the few that are cheap have limited ownership or high debt) around at 100m mCap. So honestly? In relatively short period I THINK we are going to tag 10p because Hemo is just too cheap and we have not yet seen any II buying into Hemo as CLINICAL, IMO 5p+ is all but guaranteed so that makes the mCap over 50mil which as has been called out many times is the absolute minimum before alot of IIs or funds will even consider a shares. So yea, IMO we hit 10p.... Then? I think there will be a placing to Prevail at 6p so maybe drop back to around 8p which keeps mCap around 100m for a while. But pure speculation. A massive update on licencing CDX or progress on CBR could blow that away.
Submission of Complete Response to Clinical Hold RNS
Which came 7am on a Tuesday following US Public Holiday making actual submission likely on the 12th Jan.... 18 Calendar days ago..... Leaving 12 calendar days.... Thats EIGHT trading days! MAX! Crazy, time flies when your having fun!
Episode 4: Return of Pingu.....
Game on ๐ฎ is it a sign? 7am???
After those who sold today tomorrow would be absolutely epic and Biblical, please vlad let it be tomorrow ๐ ๐ ๐ ๐
I have a dream of one day owning a million shiny hemo tickets... we can but dream...
30m mCap about to ho clinical. It's like buying a watch to sell at auction, you buy it in a shop to resell your paying the markup price. Get it at a car boot and it's a fraction of the price but there is more risk associated. NOTHING against avct, zilch, but its much much easier for Hemo to multibag than it. As for golden goose... it has its precision platform hemo has its cure for all viruses and brain cancer CBR platform, so again, apples....
Sorry for spam, bloody phone messing up
Nothing against avct, you will never find me over there deramping or cross ramping. However they are like apples and oranges. One is CLINICAL and in trials with a 300m mCap. The other is PRE-CLINICAL with a
Nothing against avct, you will never find me over there deramping or cross ramping. However they are like apples and oranges. One is CLINICAL and in trials with a 300m mCap. The other is PRE-CLINICAL with a
Ok well then ignore my posts, I appreciate its boring to you, just remember your not the target audience, its the visitors who dont know whats going on, so I close today with:
Hemogenyx currently < 30m mCap - PRE-Clinical with multiple pipelines
One of which is HEMO-CAR-T - There was a clinical hold applied, fda raised one issue which has been addressed. FDA approved plan to lift CH and work has now been done by Hemogenyx in line with that Plan. FDA have 1-2 weeks left to respond and every expectation is CH will be lifted.
This allows Hemogenyx to start clinical trials with with their CMO Prevail Infoworks and PROBABLY with additional financial backing from Prevail Partners who previously made a strategic investment at 6p. Once clinical Hemogenyx will join a limited class of CAR-T pharmas in the oncology sphere and will be the cheapest of the bunch where the field is 100-300m+ for small scaling into the billions for the larger Pharmas. Licencing deals for CAR-T in recent years have been 100s of millions into bns with up front payments, milestones and bio bucks.
Tick Tock!
Micky, Hand on my heart I have sold positions in shares where I was > 50% down.
Smart trader I knew on twitter once said to me:
"Stock or Cash its the same ยฃ1000, if your not going to buy at this price then your a fool to not sell."
So either you think this is a good investment in which case why the negativity, what happened in the past is the past and if you keep looking back your going to walk head first into a wall. If you think its a bad investment then holding and not selling is just stupid.
Bottom line is, speaking for myself and the likes of HH, Haywain, dhub etc, we are not speaking to you, we are not posting for your benefit, by and large we post for the benefit of those casual browsers who might stumble across Hemogenyx and not have a clue about whats going on, never going to read the RNS or do any research and sometimes it nice to have the bull argument here in an accessible format. If they buy and put a bit of pain on the shorters and give us a slightly higher base for when news does land? GREAT! We should all welcome that. If this annoys you please block me :P
JRDC, AVCT have an mCap of 300m, and they are in clinical trials, this is the upper edge of where I said Hemo should be, think many people miss this point, Hemogenyx are LESS than 30mil mCap, which is why its so much easier to do 100/200/300%....
As for "hey're creating a whole platform and managed something no other pharma has." They are basically trying to make chemotherapy safer... Which is basically CDX and Hemo have that aswell in the back burner, as for a whole platform, Might I suggest some background reading into CBR :P